THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE
Chirag Ambaliya, Dimple Gupta, Ashok Vala, Krupa Mukeshbhai Unadkat
PARIPEX INDIAN JOURNAL OF RESEARCH May 15, 2023 DOI: 10.36106/paripex/6712845 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Anxiety Ayahuasca MDMA Psilocybin |
| Keywords | Hallucinogen Mental health Depression economics Psychoactive substance Psychotherapist Clinical psychology |
| Key findings | Psychedelic drugs show potential as groundbreaking treatments for mental health disorders resistant to traditional therapies. |
Abstract
The purpose of this review article is to give a summary of the literature on the use of psychedelic drugs, such as psilocybin, LSD, ayahuasca, and MDMA, in the treatment of various mental health conditions, such as depression, anxiety, PTSD, and substance use disorders. This review's main goal is to highlight recent human studies on the use of particular psychedelic drugs, like psilocybin, LSD, MDMA, and ayahuasca, in the treatment of various psychiatric illnesses, such as treatment-resistant depression, post-traumatic stress disorder, end-of-life anxiety, and substance use disorders. There will also be a discussion of the safety and effectiveness as reported from both human and animal studies. Research has shown that psychedelics have the potential to become ground-breaking treatments for mental health disorders that are resistant to traditional therapies.
Comparable studies
Other narrative reviews on ayahuasca for anxiety, most cited first.